The biochemistry of neuronal necrosis: Rogue biology?

Nature Reviews Neuroscience

Volumn 4, Issue 8, 2003, Pages 672-684

  Syntichaki, Popi ^a   Tavernarakis, Nektarios ^a  

^a INSTITUTE OF MOLECULAR BIOLOGY AND BIOTECHNOLOGY   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE (CALCIUM); AMPA RECEPTOR; CATHEPSIN B; CATHEPSIN L; CYCLIC AMP; FODRIN; MAGNESIUM; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PHOSPHATIDYLINOSITOL 3 KINASE; ZINC;

APOPTOSIS; BIOCHEMISTRY; BRAIN BLOOD FLOW; CALCIUM CELL LEVEL; CELL ACTIVITY; CELL DAMAGE; CELL DEATH; CELL PH; CELL STRUCTURE; CELL SURVIVAL; CELL VACUOLE; DNA DAMAGE; DNA SYNTHESIS; GENE OVEREXPRESSION; GENETIC TRANSCRIPTION; HOMEOSTASIS; IMMUNOCYTOCHEMISTRY; IMMUNOREACTIVITY; ION TRANSPORT; LYSOSOME; MEMBRANE DEPOLARIZATION; NEMATODE; NERVE CELL NECROSIS; NEUROPATHOLOGY; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTON SODIUM EXCHANGE; REVIEW; SYNAPSE; ANIMAL; CHEMISTRY; HUMAN; NECROSIS; NERVE CELL; PATHOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION;

NEMATODA;

ANIMALS; HUMANS; NECROSIS; NEURONS; SIGNAL TRANSDUCTION;

EID: 0043238675     PISSN: 1471003X     EISSN: 14710048     Source Type: Journal    
DOI: 10.1038/nrn1174     Document Type: Article

References (184)

1. Ameisen, J. C. On the origin, evolution, and nature of programmed cell death: a timeline of four billion years. Cell Death Differ. 9, 367-393 (2002).
2. Meier, P., Finch, A. & Evan, G. Apoptosis in development. Nature 407, 796-801 (2000).
3. Metzstein, M. M., Stanfield, G. M. & Horvitz, H. R. Genetics of programmed cell death in C. elegans: past, present and future. Trends Genet. 14, 410-416 (1998).
4. Hengartner, M. O. The biochemistry of apoptosis. Nature 407, 770-776 (2000).
5. Shi, Y. A structural view of mitochondria-mediated apoptosis. Nature Struct. Biol. 8, 394-401 (2001).
6. Hetts, S. W. To die or not to die: an overview of apoptosis and its role in disease. J. Am. Med. Assoc. 279, 300-307 (1998).
7. Thompson, C. B. Apoptosis in the pathogenesis and treatment of disease. Science 267, 1456-1462 (1995).
8. Zhang, Y. & Herman, B. Ageing and apoptosis. Mech. Ageing Dev. 123, 245-260 (2002).
9. Bredesen, D. E. Genetic control of neural cell apoptosis. Perspect. Dev. Neurobiol. 3, 101-109 (1996).
10. Sastry, P S. & Rao, K. S. Apoptosis and the nervous system. J. Neurochem. 74, 1-20 (2000).
11. Troy, C. M. & Salvesen, G. S. Caspases on the brain. J. Neurosci. Res. 69, 145-150 (2002).
12. Eldadah, B. A. & Faden, A. I. Caspase pathways, neuronal apoptosis, and CNS injury. J. Neurotrauma 17, 811-829 (2000).
13. Kerr, J. F, Wyllie, A. H. & Currie, A. R. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer 26, 239-257 (1972).
14. Wyllie, A. H., Kerr, J. F. & Currie, A. R. Cellular events in the adrenal cortex following ACTH deprivation. J. Pathol. 106, ix (1972).
15. Martin, L. J. et al. Neurodegeneration in excitotoxicity, global cerebral ischemia, and target deprivation: a perspective on the contributions of apoptosis and necrosis. Brain Res. Bull. 46, 281-309 (1998).
16. Martin, L. J. Neuronal cell death in nervous system development, disease, and injury. Int. J. Mol. Med. 7, 455-478 (2001).
17. Martin, J. B. Molecular basis of the neurodegenerative disorders. N. Engl. J. Med. 340, 1970-1980 (1999).
18. Walker, N. I., Harmon, B. V, Gobe, G. C. & Kerr, J. F Patterns of cell death. Methods Achiev. Exp. Pathol. 13, 18-54 (1988).
19. Majno, G. & Joris, I. Apoptosis, oncosis, and necrosis. An overview of cell death. Am. J. Pathol. 146, 3-15 (1995).
20. Ranger, A. M., Malynn, B. A. & Korsmeyer, S. J. Mouse models of cell death. Nature Genet. 28, 113-118 (2001).
21. Richardson, H. & Kumar, S. Death to flies: Drosophila as a model system to study programmed cell death. J. Immunol. Methods 265, 21-38 (2002).
22. Baumeister, R. & Ge, L. The worm in us — Caenorhabditis elegans as a model of human disease. Trends Biotechnol. 20, 147-148 (2002).
23. Bonini, N. M. A genetic model for human polyglutamine- repeat disease in Drosophila melanogaster. Philos. Trans. R. Soc. Lond. B. 354, 1057-1060 (1999).
24. Bonini, N. M. Drosophila as a genetic approach to human neurodegenerative disease. Parkinsonism Relat. Disord. 7, 171-175 (2001).
25. Chalfie, M. & Wolinsky, E. The identification and suppression of inherited neurodegeneration in Caenorhabditis elegans. Nature 345, 410-416 (1990).
26. Davies, S. W. et al. Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation. Cell 90, 537-548 (1997).
27. Faber, P. W., Alter, J. R., MacDonald, M. E. & Hart, A. C. Polyglutamine-mediated dysfunction and apoptotic death of a Caenorhabditis elegans sensory neuron. Proc. Natl Acad. Sci. USA 96, 179-184 (1999).
28. Min, K. Drosophila as a model to study human brain degenerative diseases. Parkinsonism Relat. Disord. 7, 165-169 (2001).
29. Nass, R., Miller, D. M. & Blakely, R. D. C. elegans: a novel pharmacogenetic model to study Parkinson's disease. Parkinsonism Relat Disord. 7, 185-191 (2001).
30. Pioro, E. P. & Mitsumoto, H. Animal models of ALS. Clin. Neurosci. 3, 375-385 (1995).
31. Price, D. L., Sisodia, S. S. & Borchelt, D. R. Genetic neurodegenerative diseases: the human illness and transgenic models. Science 282, 1079-1083 (1998).
32. Leist, M. & Jaattela, M. Four deaths and a funeral: from caspases to alternative mechanisms. Nature Rev. Mol. Cell Biol. 2, 589-598 (2001).
33. Syntichaki, P. & Tavernarakis, N. Death by necrosis: uncontrollable catastrophe, or is there order behind the chaos? EMBO Rep. 3, 604-609 (2002).
34. Clarke, P. G. Developmental cell death: morphological diversity and multiple mechanisms. Anat. Embryol. 181, 195-213 (1990).
35. Savill, J. & Fadok, V. Corpse clearance defines the meaning of cell death. Nature 407, 784-788 (2000).
36. Voll, R. E. et al. Immunosuppressive effects of apoptotic cells. Nature 390, 350-351 (1997).
37. Hengartner, M. O. Apoptosis: corralling the corpses. Cell 104, 325-328 (2001).
38. Nicotera, P., Leist, M. & Manzo, L. Neuronal cell death: a demise with different shapes. Trends Pharmacol. Sci. 20, 46-51 (1999).
39. Nicotera, P. Apoptosis and age-related disorders: role of caspase-dependent and caspase-independent pathways. Toxicol. Lett. 127, 189-195 (2002).
40. Sperandio, S., de Belle, I. & Bredesen, D. E. An alternative, nonapoptotic form of programmed cell death. Proc. Natl Acad. Sci. USA 97, 14376-14381 (2000).
41. Wyllie, A. H. & Golstein, P. More than one way to go. Proc. Natl Acad. Sci. USA98, 11-13 (2001).
42. Vercammen, D. et al. Dual signaling of the Fas receptor: initiation of both apoptotic and necrotic cell death pathways. J. Exp. Med. 188, 919-930 (1998).
43. Leist, M., Single, B., Castoldi, A. F., Kuhnle, S. & Nicotera, P. Intracellular adenosine triphosphate (ATP) concentration: a switch in the decision between apoptosis and necrosis. J. Exp. Med. 185, 1481-1486 (1997).
44. Lee, J. M., Zipfel, G. J. & Choi, D. W. The changing landscape of ischaemic brain injury mechanisms. Nature 399, 7-14 (1999).
45. Ankarcrona, M. et al. Glutamate-induced neuronal death: a succession of necrosis or apoptosis depending on mitochondrial function. Neuron 15, 961-973 (1995).
46. Ferri, K. F. & Kroemer, G. Organelle-specific initiation of cell death pathways. Nature Cell Biol. 3, E255-263 (2001).
47. Colbourne, F., Sutherland, G. R. & Auer, R. N. Electron microscopic evidence against apoptosis as the mechanism of neuronal death in global ischemia. J. Neurosci. 19, 4200-4210 (1999).
48. Lipton, P. Ischemic cell death in brain neurons. Physiol. Rev. 79, 1431 -1568 (1999).
49. Kauppinen, R. A., Enkvist, K., Holopainen, I. & Akerman, K. E. Glucose deprivation depolarizes plasma membrane of cultured astrocytes and collapses transmembrane potassium and glutamate gradients. Neuroscience 26, 283-289 (1988).
50. 2+ concentration in isolated nerve terminals following metabolic inhibition: possible relevance to hypoglycaemia and anoxia. Neuroscience 27, 175-182
51. Choi, D. W. Excitotoxic cell death. J. Neurobiol. 23, 1261-1276 (1992).
52. Chen, Z. et al. Excitotoxic neurodegeneration induced by intranasal administration of kainic acid in C57BL/6 mice. Brain Res. 931, 135-145 (2002).
53. Fujikawa, D. G., Shinmei, S. S. & Cai, B. Kainic acid- induced seizures produce necrotic, not apoptotic, neurons with internucleosomal DNA cleavage: implications for programmed cell death mechanisms. Neuroscience 98, 41-53 (2000).
54. Ding, D. et al. Acidosis induces necrosis and apoptosis of cultured hippocampal neurons. Exp. Neurol. 162, 1-12 (2000).
55. Bonfoco, E., Krainc, D., Ankarcrona, M., Nicotera, P. & Lipton, S. A. Apoptosis and necrosis: two distinct events induced, respectively, by mild and intense insults with N- methyl-D-aspartate or nitric oxide/superoxide in cortical cell cultures. Proc. Natl Acad. Sci. USA 92, 7162-7166 (1995).
56. See, V. & Loeffler, J. P. Oxidative stress induces neuronal death by recruiting a protease and phosphatase-gated mechanism. J. Biol. Chem. 276, 35049-35059 (2001).
57. Mattson, M. P. Apoptosis in neurodegenerative disorders. Nature Rev. Mol. Cell Biol. 1, 120-129 (2000).
58. Taylor, J. P., Hardy, J. & Fischbeck, K. H. Toxic proteins in neurodegenerative disease. Science 296, 1991 -1995 (2002).
59. Driscoll, M. & Chalfie, M. The mec-4 gene is a member of a family of Caenorhabditis elegans genes that can mutate to induce neuronal degeneration. Nature 349, 588-593 (1991).
60. Canessa, C. M., Horisberger, J. D. & Rossier, B. C. Epithelial sodium channel related to proteins involved in neurodegeneration. Nature 361, 467-470 (1993).
61. Hall, D. H. et al. Neuropathology of degenerative cell death in Caenorhabditis elegans. J. Neurosci. 17, 1033-1045 (1997).
62. Cooper, J. D., Messer, A., Feng, A. K., Chua-Couzens, J. & Mobley, W C. Apparent loss and hypertrophy of interneurons in a mouse model of neuronal ceroid lipofuscinosis: evidence for partial response to insulin-like growth factor-1 treatment. J. Neurosci. 19, 2556-2567 (1999).
63. Katz, M. L. & Johnson, G. S. Mouse gene knockout models for the CLN2 and CLN3 forms of ceroid lipofuscinosis. Eur J. Paediatr. Neurol. 5, 109-114 (2001).
64. Blondet, B., Carpentier, G., Ait-Ikhlef, A., Murawsky, M. & Rieger, F. Motoneuron morphological alterations before and after the onset of the disease in the wobbler mouse. Brain Res. 930, 53-57 (2002).
65. Gonzalez Deniselle, M. C. et al. Progesterone neuroprotection in the Wobbler mouse, a genetic model of spinal cord motor neuron disease. Neurobiol. Dis. 11, 457-468 (2002).
66. Katayama, T. et al. Presenilin-1 mutations downregulate the signalling pathway of the unfolded-protein response. Nature Cell Biol. 1, 479-485 (1999).
67. Nixon, R. A., Mathews, P M. & Cataldo, A. M. The neuronal endosomal-lysosomal system in Alzheimer's disease. J. Alzheimers Dis. 3, 97-107 (2001).
68. Paschen, W. & Frandsen, A. Endoplasmic reticulum dysfunction — a common denominator for cell injury in acute and degenerative diseases of the brain? J. Neurochem. 79, 719-725 (2001).
69. Sherrington, R. et al. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature 375, 754-760 (1995).
70. DiFiglia, M. et al. Huntingtin is a cytoplasmic protein associated with vesicles in human and rat brain neurons. Neuron 14, 1075-1081 (1995).
71. Brown, R. H. Jr. Amyotrophic lateral sclerosis: recent insights from genetics and transgenic mice. Cell 80, 687-692 (1995).
72. Julien, J. P, Cote, F. & Collard, J. F. Mice overexpressing the human neurofilament heavy gene as a model of ALS. Neurobiol. Aging 16, 487-490 (1995).
73. Wong, P C. et al. An adverse property of a familial ALS- linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria. Neuron 14, 1105-1116 (1995).
74. Treinin, M. & Chalfie, M. A mutated acetylcholine receptor subunit causes neuronal degeneration in C. elegans. Neuron 14, 871-877 (1995).
75. Korswagen, H. C., Park, J. H., Ohshima, Y & Plasterk, R. H. An activating mutation in a Caenorhabditis elegans Gs protein induces neural degeneration. Genes Dev. 11, 1493-1503 (1997).
76. Berger, A. J., Hart, A. C. & Kaplan, J. M. Ga-induced neurodegeneration in Caenorhabditis elegans. J. Neurosci. 18, 2871-2880 (1998).
77. Scott, B. A., Avidan, M. S. & Crowder, C. M. Regulation of hypoxic death in C. elegans by the insulin/IGF receptor homolog DAF-2. Science 296, 2388-2391 (2002).
78. 2+ release from the endoplasmic reticulum. Neuron 31, 957-971 (2001).
79. Syntichaki, P., Xu, K., Driscoll, M. & Tavernarakis, N. Specific aspartyl and calpain proteases are required for neurodegeneration in C. elegans. Nature 419, 939-944 (2002)
80. Lipton, S. A. & Nicotera, P. Calcium, free radicals and excitotoxins in neuronal apoptosis. Cell Calcium 23, 165-171 (1998).
81. Mattson, M. P et al. Calcium signaling in the ER: its role in neuronal plasticity and neurodegenerative disorders. Trends Neurosci. 23, 222-229 (2000).
82. Sattler, R. & Tymianski, M. Molecular mechanisms of calcium- dependent excitotoxicity. J. Mol. Med. 78, 3-13 (2000).
83. Harbinder, S. et al. Genetically targeted cell disruption in Caenorhabditis elegans. Proc. Natl Acad. Sci. USA 94, 13128-13133 (1997).
84. Garcia-Anoveros, J., Garcia, J. A., Liu, J. D. & Corey, D. P. The nematode degenerin UNC-105 forms ion channels that are activated by degeneration- or hypercontraction-causing mutations. Neuron 20, 1231-1241 (1998).
85. Goodman, M. B. et al. MEC-2 regulates C. elegans DEG/ENaC channels needed for mechanosensation. Nature 415, 1039-1042 (2002).
86. Waldmann, R., Champigny, G., Voilley, N., Lauritzen, I. & Lazdunski, M. The mammalian degenerin MDEG, an amiloride-sensitive cation channel activated by mutations causing neurodegeneration in Caenorhabditis elegans. J. Biol. Chem. 271, 10433-10436 (1996).
87. Tavernarakis, N., Shreffler, W., Wang, S. & Driscoll, M. unc-8, a DEG/ENaC family member, encodes a subunit of a candidate mechanically gated channel that modulates C. elegans locomotion. Neuron 18, 107-119 (1997).
88. Chelur, D. S. et al. The mechanosensory protein MEC-6 is a subunit of the C. elegans touch-cell degenerin channel. Nature 420, 669-673 (2002).
89. Treinin, M., Gillo, B., Liebman, L. & Chalfie, M. Two functionally dependent acetylcholine subunits are encoded in a single Caenorhabditis elegans operon. Proc. Natl Acad. Sci. USA 95, 15492-15495 (1998).
90. Yassin, L. et al. Characterization of the deg-3/des-2 receptor: a nicotinic acetylcholine receptor that mutates to cause neuronal degeneration. Mol. Cell. Neurosci. 17, 589-599 (2001).
91. Korswagen, H. C., van der Linden, A. M. & Plasterk, R. H. G protein hyperactivation of the Caenorhabditis elegans adenylyl cyclase SGS-1 induces neuronal degeneration. EMBO J. 17, 5059-5065 (1998).
92. Koike, T, Tanaka, S., Oda, T. & Ninomiya, T. Sodium overload through voltage-dependent Na+ channels induces necrosis and apoptosis of rat superior cervical ganglion cells in vitro. Brain Res. Bull. 51, 345-355 (2000).
93. Paschen, W. Dependence of vital cell function on endoplasmic reticulum calcium levels: implications for the mechanisms underlying neuronal cell injury in different pathological states. Cell Calcium 29, 1-11 (2001).
94. Carafoli, E. Calcium signaling: a tale for all seasons. Proc. Natl Acad. Sci. USA 99, 1115-1122 (2002).
95. Llewellyn, D. H., Johnson, S. & Eggleton, P Calreticulin comes of age. Trends Cell Biol. 10, 399-402 (2000).
96. Michalak, M., Corbett, E. F., Mesaeli, N., Nakamura, K. & Opas, M. Calreticulin: one protein, one gene, many functions. Biochem. J. 344, 281-292 (1999).
97. Putney, J. W. Jr. Excitement about calcium signaling in inexcitable cells. Science 262, 676-678 (1993).
98. Ghosh, A. & Greenberg, M. E. Calcium signaling in neurons: molecular mechanisms and cellular consequences. Science 268, 239-247 (1995).
99. Fahn, S. & Cohen, G. The oxidant stress hypothesis in Parkinson's disease: evidence supporting it. Ann. Neurol. 32, 804-812 (1992).
100. Behl, C. & Moosmann, B. Oxidative nerve cell death in Alzheimer's disease and stroke: antioxidants as neuroprotective compounds. Biol. Chem. 383, 521-536 (2002).
101. Johnston, J. A., Dalton, M. J., Gurney, M. E. & Kopito, R. R. Formation of high molecular weight complexes of mutant Cu, Zn-superoxide dismutase in a mouse model for familial amyotrophic lateral sclerosis. Proc. Natl Acad. Sci. USA 97, 12571-12576 (2000).
102. Mockett, R. J., Radyuk, S. N., Benes, J. J., Orr, W. C. & Sohal, R. S. Phenotypic effects of familial amyotrophic lateral sclerosis mutant Sod alleles in transgenic Drosophila. Proc. Natl Acad. Sci. USA100, 301-306 (2003).
103. Yu, G., Zucchi, R., Ronca-Testoni, S. & Ronca, G. Protection of ischemic rat heart by dantrolene, an antagonist of the sarcoplasmic reticulum calcium release channel. Basic Res. Cardiol. 95, 137-143 (2000).
104. Takemura, H., Hughes, A. R., Thastrup, O. & Putney, J. W. Jr. Activation of calcium entry by the tumor promoter thapsigargin in parotid acinar cells. Evidence that an intracellular calcium pool and not an inositol phosphate regulates calcium fluxes at the plasma membrane. J. Biol. Chem. 264, 12266-12271 (1989).
105. Rao, R. V. et al. Coupling endoplasmic reticulum stress to the cell death program: role of the ER chaperone GRP78. FEBS Lett. 514, 122-128 (2002).
106. Shen, X. et al. Complementary signaling pathways regulate the unfolded protein response and are required for C. elegans development. Cell107, 893-903 (2001).
107. Ryu, E. J. et al. Endoplasmic reticulum stress and the unfolded protein response in cellular models of Parkinson's disease. J. Neurosci. 22, 10690-10698 (2002).
108. 2+ efflux in rat forebrain neurones in culture. J. Physiol. (Lond.) 492, 641-657 (1996).
109. 2+ entry produces oxidative neuronal necrosis in cortical cell cultures. Eur. J. Neurosci. 11, 327-334 (1999).
110. Auer, R. N. Non-pharmacologic (physiologic) neuroprotection in the treatment of brain ischemia. Ann. NY Acad. Sci. 939, 271-282 (2001).
111. Kim, Y. H., Kim, E. Y., Gwag, B. J., Sohn, S. & Koh, J. Y. Zinc- induced cortical neuronal death with features of apoptosis and necrosis: mediation by free radicals. Neuroscience 89, 175-182 (1999).
112. 2+ induces permeability transition pore opening and release of pro-apoptotic peptides from neuronal mitochondria. J. Biol. Chem. 276, 47524-47529 (2001).
113. Lobner, D. et al. Zinc-induced neuronal death in cortical neurons. Cell. Mol. Biol. 46, 797-806 (2000).
114. Coakley R. J., Taggart, C., McElvaney N. G. & O'Neill, S. J. Cytosolic pH and the inflammatory microenvironment modulate cell death in human neutrophils after phagocytosis. Blood 100, 3383-3391 (2002).
115. Sapolsky, R. M., Trafton, J. & Tombaugh, G. C. Excitotoxic neuron death, acidotic endangerment, and the paradox of acidotic protection. Adv. Neurol. 71, 237-244 (1996).
116. Gisselsson, L., Smith, M. L. & Siesjo, B. K. Hyperglycemia and focal brain ischemia. J. Cereb. Blood Flow Metab. 19, 288-297 (1999).
117. Katsura, K., Kristian, T., Smith, M. L. & Siesjo, B. K. Acidosis induced by hypercapnia exaggerates ischemic brain damage. J. Cereb. Blood Flow Metab. 14, 243-250 (1994).
118. Affar el, B., Shah, R. G., Dallaire, A. K., Castonguay V & Shah, G. M. Role of poly(ADP-ribose) polymerase in rapid intracellular acidification induced by alkylating DNA damage. Proc. Natl Acad. Sci. USA99, 245-250 (2002).
119. Sauvage, M., Maziere, P., Fathallah, H. & Giraud, F. Insulin stimulates NHE1 activity by sequential activation of phosphatidylinositol 3-kinase and protein kinase CZ in human erythrocytes. Eur. J. Biochem. 267, 955-962 (2000).
120. Kenessey, A., Nacharaju, P, Ko, L. W. & Yen, S. H. Degradation of tau by lysosomal enzyme cathepsin D: implication for Alzheimer neurofibrillary degeneration. J. Neurochem. 69, 2026-2038 (1997).
121. Xue, L., Fletcher, G. C. & Tolkovsky, A. M. Autophagy is activated by apoptotic signalling in sympathetic neurons: an alternative mechanism of death execution. Mol. Cell. Neurosci. 14, 180-198 (1999).
122. Yamashima, T. Implication of cysteine proteases calpain, cathepsin and caspase in ischemic neuronal death of primates. Prog. Neurobiol. 62, 273-295 (2000).
123. Adamec, E., Mohan, P. S., Cataldo, A. M., Vonsattel, J. P. & Nixon, R. A. Up-regulation of the lysosomal system in experimental models of neuronal injury: implications for Alzheimer's disease. Neuroscience 100, 663-675 (2000).
124. Hetman, M., Filipkowski, R. K., Domagala, W. & Kaczmarek, L. Elevated cathepsin D expression in kainate-evoked rat brain neurodegeneration. & qp. Neurol. 136, 53-63 (1995).
125. Seyfried, D. M. et al. A selective cysteine protease inhibitor is non-toxic and cerebroprotective in rats undergoing transient middle cerebral artery ischemia. Brain Res. 901, 94-101 (2001).
126. Bi, X., Yong, A. P, Zhou, J., Gall, C. M. & Lynch, G. Regionally selective changes in brain lysosomes occur in the transition from young adulthood to middle age in rats. Neuroscience 97, 395-404 (2000).
127. Bednarski, E. & Lynch, G. Cytosolic proteolysis of tau by cathepsin D in hippocampus following suppression of cathepsins B and L. J. Neurochem. 67, 1846-1855 (1996).
128. Loftus, S. K et al. Murine model of Niemann-Pick C disease: mutation in a cholesterol homeostasis gene. Science 277, 232-235 (1997).
129. Vanier, M. T. & Suzuki, K. Recent advances in elucidating Niemann-Pick C disease. Brain Patiol. 8, 163-174 (1998).
130. Nixon, R. A. A 'protease activation cascade' in the pathogenesis of Alzheimer's disease. Ann. NY Acad. Sci. 924, 117-131 (2000).
131. Bi, X. et al. Novel cathepsin D inhibitors block the formation of hyperphosphorylated tau fragments in hippocampus. J. Neurochem. 74, 1469-1477 (2000).
132. Crawford, F C. et al. The genetic association between cathepsin D and Alzheimer's disease. Neurosci. Lett. 289, 61-65 (2000).
133. Jung, H., Lee, E. Y & Lee, S. I. Age-related changes in ultrastructural features of cathepsin B- and D-containing neurons in rat cerebral cortex. Brain Res. 844, 43-54 (1999).
134. Yamakawa, H. et al. Crucial role of calpain in hypoxic PC12 cell death: calpain, but not caspases, mediates degradation of cytoskeletal proteins and protein kinase C-a and 5. Neurol. Res. 23, 522-530 (2001).
135. Aki, T., Yoshida, K & Fujimiya, T. Phosphoinositide 3-kinase accelerates calpain-dependent proteolysis of fodrin during hypoxic cell death. J. Biochem. (Tokyo) 132, 921-926 (2002).
136. 2+ homeostasis in the regulation of apoptotic and necrotic cell deaths. Cell Calcium 28, 107-117 (2000).
137. Wang, K. K. Calpain and caspase: can you tell the difference? Trends Neurosci. 23, 20-26 (2000).
138. Shi, Y, Melnikov, V. Y, Schrier, R. W. & Edelstein, C. L. Downregulation of the calpain inhibitor protein calpastatin by caspases during renal ischemia-reperfusion. Am. J. Physiol. Renal Physiol. 279, F509-F517 (2000).
139. Schwab, B. L. et al. Cleavage of plasma membrane calcium pumps by caspases: a link between apoptosis and necrosis. Cell Death Differ. 9, 818-831 (2002).
140. Yamamoto, A., Lucas, J. J. & Hen, R. Reversal of neuropathology and motor dysfunction in a conditional model of Huntington's disease. Cell 101, 57-66 (2000).
141. Lauritzen, I., De Weille, J. R. & Lazdunski, M. The potassium channel opener (-)-cromakalim prevents glutamate-induced cell death in hippocampal neurons. J. Neurochem. 69, 1570-1579 (1997).
142. McGinnis, K. M., Wang, K. K. & Gnegy, M. E. Alterations of extracellular calcium elicit selective modes of cell death and protease activation in SH-SY5Y human neuroblastoma cells. J. Neurochem. 72, 1853-1863 (1999).
143. McMahon, A. et al. Calbindin-D28k buffers intracellular calcium and promotes resistance to degeneration in PC12 cells. Brain Res. Mol. Brain Res. 54, 56-63 (1998).
144. Tsuchiya, K. et al. Postictal blockade of ischemic hippocampal neuronal death in primates using selective cathepsin inhibitors. Exp. Neurol. 155, 187-194 (1999).
145. Yamashima, T., Zhao, L., Wang, X. D., Tsukada, T & Tonchev, A. B. Neuroprotective effects of pyridoxal phosphate and pyridoxal against ischemia in monkeys. Nutr. Neurosci. 4, 389-397 (2001).
146. Wang, X. D. et al. Vitamin B6 protects primate retinal neurons from ischemic injury. Brain Res. 940, 36-43 (2002).
147. Hengartner, M. O. & Horvitz, H. R. Programmed cell death in Caenorhabditis elegans. Curr. Opin. Genet. Dev. 4, 581-586 (1994).
148. Kaufmann, S. H. & Hengartner, M. O. Programmed cell death: alive and well in the new millennium. Trends Cell Biol. 11, 526-534 (2001).
149. Soto, C. Protein misfolding and disease; protein refolding and therapy. FEBS Lett. 498, 204-207 (2001).
150. Cleveland, D. W. & Rothstein, J. D. From Charcot to Lou Gehrig: deciphering selective motor neuron death in ALS. Nature Rev. Neurosci. 2, 806-819 (2001).
151. Aldhous, P & Abbott, A. Neurodegeneration. Battling the killer proteins. Nature 408, 902-903 (2000).
152. Soto, C. Unfolding the role of protein misfolding in neurodegenerative diseases. Nature Rev. Neurosci. 4, 49-60 (2003).
153. Bucciantini, M. et al. Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases. Nature 416, 507-511 (2002).
154. Bence, N. F., Sampat, R. M. & Kopito, R. R. Impairment of the ubiquitin-proteasome system by protein aggregation. Science 292, 1552-1555 (2001).
155. Sanchez, I., Mahlke, C. & Yuan, J. Pivotal role of oligomerization in expanded polyglutamine neurodegenerative disorders. Nature 421, 373-379 (2003).
156. Kazemi-Esfarjani, P & Benzer, S. Genetic suppression of polyglutamine toxicity in Drosophila. Science 287, 1837-1840 (2000).
157. Caldwell, G. A. et al. Suppression of polyglutamine-induced protein aggregation in Caenorhabditis elegans by torsin proteins. Hum. Mol. Genet. 12, 307-319 (2003).
158. Chan, H. Y., Warrick, J. M., Gray-Board, G. L., Paulson, H. L. & Bonini, N. M. Mechanisms of chaperone suppression of polyglutamine disease: selectivity, synergy and modulation of protein solubility in Drosophila. Hum. Mol. Genet. 9, 2811-2820 (2000).
159. Cummings, C. J. et al. Over-expression of inducible HSP70 chaperone suppresses neuropathology and improves motor function in SCA1 mice. Hum. Mol. Genet. 10, 1511-1518 (2001).
160. Krobitsch, S. & Lindquist, S. Aggregation of huntingtin in yeast varies with the length of the polyglutamine expansion and the expression of chaperone proteins. Proc. Natl Acad. Sci. USA 97, 1589-1594 (2000).
161. Satyal, S. H. et al. Polyglutamine aggregates alter protein folding homeostasis in Caenorhabditis elegans. Proc. Natl Acad. Sci. USA 97, 5750-5755 (2000).
162. Fonte, V. et al. Interaction of intracellular p amyloid peptide with chaperone proteins. Proc. Natl Acad. Sci. USA 99, 9439-9444 (2002).
163. Link, C. D. Expression of human p-amyloid peptide in transgenic Caenorhabditis elegans. Proc. Natl Acad. Sci. USA 92, 9368-9372 (1995).
164. Auluck, P K., Chan, H. Y., Trojanowski, J. Q., Lee, V M. & Bonini, N. M. Chaperone suppression of a-synuclein toxicity in a Drosophila model for Parkinson's disease. Science 295, 865-868 (2002).
165. Yoshida, M. et al. Primate neurons show different vulnerability to transient ischemia and response to cathepsin inhibition. Acta Neuropathol. (Berl.) 104, 267-272 (2002).
166. Morganti-Kossmann, M. C., Rancan, M., Stahel, P. F. & Kossmann, T. Inflammatory response in acute traumatic brain injury: a double-edged sword. Curr. Opin. Crit. Care 8, 101-105 (2002).
167. Grabb, M. C., Lobner, D., Turetsky, D. M. & Choi, D. W. Preconditioned resistance to oxygen-glucose deprivation- induced cortical neuronal death: alterations in vesicular GABA and glutamate release. Neuroscience 115, 173-183 (2002).
168. Kaminogo, M., Suyama, K., Ichikura, A., Onizuka, M. & Shibata, S. Anoxic depolarization determines ischemic brain injury. Neurol. Res. 20, 343-348 (1998).
169. Dzhala, V, Ben-Ari, Y. & Khazipov, R. Seizures accelerate anoxia-induced neuronal death in the neonatal rat hippocampus. Ann. Neurol. 48, 632-640 (2000).
170. Holmes, G. L. Seizure-induced neuronal injury: animal data. Neurology 59, S3-6 (2002).
171. Fern, R. & Moller, T. Rapid ischemic cell death in immature oligodendrocytes: a fatal glutamate release feedback loop. J. Neurosci. 20, 34-42 (2000).
172. - exchange in regulation of intracellular pH in fibroblasts. J. Biol. Chem. 260, 4877-4883 (1985).
173. Lodish, H. F. Molecular Cell Biology (W. H. Freeman, New York, 2000).
174. Putney, L. K., Denker, S. P. & Barber, D. L. The changing face of the Na+/H+ exchanger, NHE1: structure, regulation, and cellular actions. Annu. Rev. Pharmacol. Toxicol. 42, 527-552 (2002).
175. +)-ATPase. Annu. Rev. Cell Dev. Biol. 13, 779-808 (1997).
176. Yamashima, T et al. Inhibition of ischaemic hippocampal neuronal death in primates with cathepsin B inhibitor CA-074: a novel strategy for neuroprotection based on 'calpain-cathepsin hypothesis'. Eur. J. Neurosci. 10, 1723-1733 (1998).
177. Decker, R. S., Poole, A. R., Crie, J. S., Dingle, J. T. & Wildenthal, K. Lysosomal alterations in hypoxic and reoxygenated hearts. II. Immunohistochemical and biochemical changes in cathepsin D. Am. J. Pathol. 98, 445-456 (1980).
178. de Duve, C. Lysosomes revisited. Eur. J. Biochem. 137, 391-397 (1983).
179. Xue, L., Fletcher, G. C. & Tolkovsky, A. M. Mitochondria are selectively eliminated from eukaryotic cells after blockade of caspases during apoptosis. Curr. Biol. 11, 361-365 (2001).
180. Vitale, M., Zauli, G. & Falcieri, E. in Apoptosis: a Lab Manual of Experimental Methods (eds Cossarizza, A. & Boraschi, D.) CD-ROM Purdue Cytometry Vol. 4 http://scooter. cyto.purdue.edu/pucl_cd/flow/vol4/15_apop/data/index.htm (Purdue Univ. Cytometry Laboratories, West Lafayette, 1997)
181. Kristian, T. & Siesjo, B. K. Calcium in ischemic cell death. Stroke 29, 705-718 (1998).
182. Halestrap, A. P., Kerr, P M., Javadov, S. & Woodfield, K. Y. Elucidating the molecular mechanism of the permeability transition pore and its role in reperfusion injury of the heart. Biochim. Biophys. Acta 1366, 79-94 (1998).
183. Lemasters, J. J. et al. The mitochondrial permeability transition in cell death: a common mechanism in necrosis, apoptosis and autophagy. Biochim. Biophys. Acta 1366, 177-196 (1998).
184. Nicholls, D. G., Budd, S. L., Ward, M. W. & Castilho, R. F. Excitotoxicity and mitochondria. Biochem. Soc. Symp. 66, 55-67 (1999).